| Speakers/Presentations | Time EST | Time CET |
|
Khosrow Kashfi Opening Remarks |
8:30am | 2.30pm |
|
David A. Wink Keynote Speaker |
9:00am | 3.00pm |
|
Giuseppe Filomeni Redox activation of ATM modulates S-nitrosylation and mitophagy: effects on immune cell activation |
10:00am | 4.00pm |
|
Sharon Glynn Influence of nitric oxide on prostate cancer initiation and progression |
10:25am | 4.25pm |
|
Melanie Flint
|
10:50am | 4.50pm |
|
Salvatore Rizza Exploiting S-nitrosylation for cancer therapy: facts and perspectives |
11:15am | 5.15pm |
|
Asghar Ghasemi Nitrate and nitrite for management of type 2 diabetes: Translation from |
11:40am | 5.40pm |
|
Sruti Shiva Nitrite activates PKA to regulate cardiomyocyte function |
12:05pm | 6.05pm |
|
Probal Banerjee Exploiting the Diverse Roles of Nitric Oxide Synthase Isozymes |
12:30pm | 6.30pm |
|
Roshale Fernando Normalizing arginine metabolism in tumor associated macrophages: A novel immunotherapeutic strategy for breast cancer |
12:55pm | 6.55pm |
-
| Speakers/Presentations | Time EST | Time CET |
|
Khosrow Kashfi Opening Remarks |
08:30am | 14.30pm |
|
Thiago Cunha NO signaling mediates peripheral analgesia |
09:00am | 15.00pm |
|
Jordi Muntané Relevance of NO downregulation during the treatment of liver cancer with Sorafenib |
09:25am | 15.25pm |
|
Sevda Gheibi Hydrogen sulfide potentiates the favorable metabolic profile of inorganic nitrite in type 2 diabetes |
09:50am | 15.50pm |
|
Carola Neumann Nitroalkenes and cancer: an update on anti-cancer drug development efforts |
10:15am | 16.15pm |
|
Break |
10.40am | 16.40pm |
|
Dipak Panigrahy
|
10:55am | 16.55pm |
|
Douglas Thomas Nitric oxide; the new architect of epigenetic landscapes |
11:20am | 17.20pm |
|
Bindu D. Paul Role of nitrosylation and sulfhydration in aging and neurodegeneration |
11:45am | 17.45pm |
|
Khosrow Kashfi NOSH-aspirin (NBS-1120), a multitarget inhibitor for the treatment of |
12:10pm | 18.10pm |